Elizabeth Desjardins

Dana-Farber Cancer Institute

Papers

1

Total Citations

112

H-Index

1

About

Elizabeth Desjardins is a leading structural biologist whose work has fundamentally advanced our understanding of viral glycoproteins, particularly in the context of HIV-1. Her key research areas include protein crystallization, biophysical characterization of viral envelope proteins, and the development of probabilistic methods for structural biology. Desjardins’s most notable contribution is her pioneering application of probability analysis to overcome the extreme challenges of crystallizing gp120, the heavily glycosylated and conformationally flexible envelope glycoprotein of HIV-1. Her landmark 1999 paper on this subject, which has garnered 112 citations, provided a critical methodological framework that enabled subsequent high-resolution structural studies of this key target for vaccine design. By systematically identifying the most effective crystallization conditions through statistical modeling, Desjardins helped break a major bottleneck in HIV research. Her work has had a lasting impact on the field, demonstrating how rigorous analytical approaches can solve problems that resist conventional experimental techniques. Desjardins remains an influential figure in structural virology, and her methodological innovations continue to guide researchers working on difficult-to-crystallize proteins.

Research Focus

Key Achievements

1
H-Index
1
Papers
112
Total Citations
112
Avg Citations/Paper
🏆 Most Cited Paper
Probability Analysis of Variational Crystallization and Its Application to gp120, The Exterior Envelope Glycoprotein of Type 1 Human Immunodeficiency Virus (HIV-1)
112 citations · 1999
📈 Most Prolific Year: 1999 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Dana-Farber Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago